medrxiv Subject Collection: Psychiatry And Clinical Psychology
http://medrxiv.org
This feed contains articles for medRxiv Subject Collection "Psychiatry And Clinical Psychology"
medrxivmedrxivhttps://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png
http://medrxiv.org
<![CDATA[
An Interpretable Deep Learning Framework Reveals Frontoparietal Control Network Hyperactivation Underlying Autism Diagnosis and Symptom Severity
]]>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351834v1?rss=1
2026-04-29doi:10.64898/2026.04.28.26351834Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Blunted maturation of inhibitory control circuits in the NAC-shell underlies genetic vulnerability to early-life obesity and impulsivity
]]>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351915v1?rss=1
2026-04-29doi:10.64898/2026.04.28.26351915Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Divergent Cognitive Trajectories by Gamma Center Frequency Plasticity After Personalized Gamma Entrainment in Early Alzheimer Disease: A Dechallenge Analysis
]]>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351905v1?rss=1
=2 Hz; n=5) or ICF- (no CF increase; n=7). MMSE trajectories from baseline to week 12 and from week 12 to final follow-up were analyzed using piecewise linear mixed-effects models. Results: Baseline characteristics, including MMSE, did not differ significantly between groups. During intervention, MMSE was stable in ICF+ (+0.27 points/month; 95% CI, -0.20 to 0.73) but declined in ICF- (-0.69 points/month; 95% CI, -1.07 to -0.30; between-group p=0.011). After cessation, estimated slopes were similar in ICF+ and ICF- (-0.16 vs -0.17 points/month; p=0.968), and the phase-by-group interaction was significant (p=0.006). Medication intensification during follow-up was more common in ICF-, including antipsychotic initiation in 4 of 7 participants. Conclusions: In this exploratory post hoc analysis, lack of CF plasticity was associated with accelerated cognitive decline during the intervention phase but not during follow-up. This temporal pattern is consistent with, but does not establish, a dechallenge-like safety signal. Given the small sample, post hoc stratification, and differential medication changes, these findings should be considered hypothesis-generating and require prospective validation with pre-defined electrophysiologic stratification.
]]>2026-04-29doi:10.64898/2026.04.28.26351905Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Cognitive reserve and gamma entrainment-related network changes in prodromal Alzheimer's disease
]]>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351913v1?rss=1
2026-04-29doi:10.64898/2026.04.28.26351913Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Frequency Mismatch Critically Limits Gamma Entrainment: A Kuramoto Model Study Supporting Personalized GENUS Therapy
]]>
https://www.medrxiv.org/content/10.64898/2026.04.28.26351909v1?rss=1
2026-04-29doi:10.64898/2026.04.28.26351909Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Neural and behavioural measures from attention testing show no support for efficacy of neurofeedback treatment for adult ADHD
]]>
https://www.medrxiv.org/content/10.64898/2026.04.26.26351764v1?rss=1
2026-04-28doi:10.64898/2026.04.26.26351764Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Personalized, EEG-controlled intermittent theta burst stimulation
]]>
https://www.medrxiv.org/content/10.64898/2026.04.27.26351877v1?rss=1
2026-04-28doi:10.64898/2026.04.27.26351877Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Identifying autism in women diagnosed with borderline personality disorder: Clinician and lived experience perspectives.
]]>
https://www.medrxiv.org/content/10.64898/2026.04.27.26351287v1?rss=1
2026-04-28doi:10.64898/2026.04.27.26351287Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Reconciling neurocognitive and behavioral impulsivities through ecological assessment and multivariate modelling of cognitive control dynamics
]]>
https://www.medrxiv.org/content/10.64898/2026.04.27.26351677v1?rss=1
2026-04-28doi:10.64898/2026.04.27.26351677Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Psychomotor retardation and risk of Parkinson's disease in unipolar depression: a retrospective cohort study
]]>
https://www.medrxiv.org/content/10.64898/2026.04.26.26351763v1?rss=1
10 years prior to Parkinsons diagnosis.
C_LIO_LIDepression with psychomotor retardation may be a prodrome for Parkinsons disease.
C_LI
]]>2026-04-27doi:10.64898/2026.04.26.26351763Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Individualized cortical gradient and network topology reveal symptom-linked disruptions and neurobiological subtypes in schizophrenia
]]>
https://www.medrxiv.org/content/10.64898/2026.04.25.26351736v1?rss=1
2026-04-27doi:10.64898/2026.04.25.26351736Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Neighborhood Deprivation Is Associated with Accelerated Epigenetic Aging Via Greater Individual Adversity
]]>
https://www.medrxiv.org/content/10.64898/2026.04.24.26351669v1?rss=1
2026-04-27doi:10.64898/2026.04.24.26351669Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Neurobehavioral Profiles of Inhibitory-Control Stratify Vulnerability and Resilience under Childhood Poverty
]]>
https://www.medrxiv.org/content/10.64898/2026.04.18.26350994v1?rss=1
2026-04-27doi:10.64898/2026.04.18.26350994Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Toward trustworthy clinical AI for obsessive-compulsive disorder: reliability, generalizability, and interpretability of a transformer model across the ENIGMA-OCD consortium
]]>
https://www.medrxiv.org/content/10.64898/2026.04.24.26351711v1?rss=1
2026-04-27doi:10.64898/2026.04.24.26351711Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Estimating direct and indirect genetic effects on variation in depressive symptoms in early adolescence: a trio PGS analysis in the MoBa cohort
]]>
https://www.medrxiv.org/content/10.64898/2026.04.17.26350751v1?rss=1
2026-04-25doi:10.64898/2026.04.17.26350751Cold Spring Harbor Laboratory2026-04-25
<![CDATA[
When Data Meets Practice: A Qualitative Study of Clinician Perspectives on Streaming Data in Mental Health
]]>
https://www.medrxiv.org/content/10.64898/2026.04.23.26351640v1?rss=1
2026-04-25doi:10.64898/2026.04.23.26351640Cold Spring Harbor Laboratory2026-04-25
<![CDATA[
Assessing Parent-cocreated Sensory Reactivity Outcomes in Children with Neurodevelopmental Disorders Undergoing Bumetanide Treatment: A Multiple-Baseline Single-Case Experimental Design
]]>
https://www.medrxiv.org/content/10.64898/2026.04.22.26351464v1?rss=1
2026-04-23doi:10.64898/2026.04.22.26351464Cold Spring Harbor Laboratory2026-04-23
<![CDATA[
Artificial Intelligence Agents in Mental Health: A Systematic Review and Meta Analysis
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26351365v1?rss=1
2026-04-22doi:10.64898/2026.04.21.26351365Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Digital Therapeutic for Hwa-byung Based on Acceptance and Commitment Therapy: A Pilot Feasibility Trial
]]>
https://www.medrxiv.org/content/10.64898/2026.04.19.26351203v1?rss=1
2026-04-22doi:10.64898/2026.04.19.26351203Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Rare protein-disrupting variants in NPY5R, DLGAP1 and MAPK8IP3 segregate with OCD in two multiplex pedigrees potentially implicating energy homeostasis and post-synaptic signalling in molecular etiology.
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26350600v1?rss=1
2026-04-22doi:10.64898/2026.04.21.26350600Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Common Substrates of Early Illness Severity: Clinical, Genetic, and Brain Evidence
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26350991v1?rss=1
2026-04-22doi:10.64898/2026.04.21.26350991Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Menopausal hormone therapy at age 45 to 60 years old, future dementia or cognitive decline: Systematic review and meta-analysis
]]>
https://www.medrxiv.org/content/10.64898/2026.04.20.26351058v1?rss=1
2026-04-22doi:10.64898/2026.04.20.26351058Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Violence exposure and mental health problems among school-aged children in a South African birth cohort
]]>
https://www.medrxiv.org/content/10.64898/2026.04.20.26351289v1?rss=1
2026-04-22doi:10.64898/2026.04.20.26351289Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Anterior Cingulate Cortex Sulcal Patterns associated with Catatonia across Schizophrenia and Mood Disorders
]]>
https://www.medrxiv.org/content/10.64898/2026.04.20.26351285v1?rss=1
2026-04-22doi:10.64898/2026.04.20.26351285Cold Spring Harbor Laboratory2026-04-22
<![CDATA[
Family Constellations for All Clinical Conditions: A Systematic Review and Meta-analysis Showing a Lack of Supporting Evidence
]]>
https://www.medrxiv.org/content/10.64898/2026.04.19.26351231v1?rss=1
2026-04-21doi:10.64898/2026.04.19.26351231Cold Spring Harbor Laboratory2026-04-21
<![CDATA[
Subtypes of Internalizing and Externalizing Problems in Autistic Preschool Children: Participation in Daily Life and Family Outcomes
]]>
https://www.medrxiv.org/content/10.64898/2026.04.14.26350723v1?rss=1
2026-04-21doi:10.64898/2026.04.14.26350723Cold Spring Harbor Laboratory2026-04-21
<![CDATA[
A fully remote randomized controlled trial of an ultra-brief digital meditation intervention reduces internalizing symptoms
]]>
https://www.medrxiv.org/content/10.64898/2026.04.19.26351219v1?rss=1
2026-04-21doi:10.64898/2026.04.19.26351219Cold Spring Harbor Laboratory2026-04-21
<![CDATA[
Striatal dopamine synthesis in schizophrenia decreases from psychosis to psychotic remission
]]>
https://www.medrxiv.org/content/10.64898/2026.04.20.26351256v1?rss=1
2026-04-21doi:10.64898/2026.04.20.26351256Cold Spring Harbor Laboratory2026-04-21
<![CDATA[
Rethinking covariate adjustment in psychiatric biomarker research: a framework applied to UK Biobank blood samples
]]>
https://www.medrxiv.org/content/10.64898/2026.04.19.26351233v1?rss=1
2026-04-21doi:10.64898/2026.04.19.26351233Cold Spring Harbor Laboratory2026-04-21
<![CDATA[
Semaglutide Initiation and Treatment Duration On Suicidality Risk in US Veterans With Type 2 Diabetes
]]>
https://www.medrxiv.org/content/10.64898/2026.04.17.26351118v1?rss=1
12 months).
OutcomesIncident suicidal ideation; suicide attempt or death; and a composite outcome.
ResultsA total of 102,361 Veterans met inclusion criteria, including 11,478 new initiators of semaglutide and 90,883 new initiators of an SGLT2i. After overlap weighting, baseline characteristics were well balanced between treatment groups (mean [SD] age, 60.1 [11.7] years; BMI, 37.8 [6.8] kg/m2; hemoglobin A1c, 7.0% [1.4]; 85.5% male; 61.9% non-Hispanic White). During a median follow-up of 2.2 years, 9077 incident suicidal ideation events and 696 suicide attempts or deaths occurred. The incidence rate of suicidal ideation was 56.3 and 37.7 per 1000 person-years among semaglutide initiators and SGLT2i initiators, respectively (hazard ratio [HR], 0.99; 95% CI, 0.93-1.06; P = 0.86). For suicide attempts or deaths, the incidence rates were 4.30 and 2.64 per 1000 person-years, respectively (HR, 1.05; 95% CI, 0.84-1.31; P = .86). In adherence-adjusted analyses, sustained semaglutide treatment for more than 12 months, compared with 6 or fewer months, was associated with a 74% lower risk of suicide attempts or deaths (HR, 0.27; 95% CI, 0.14-0.54; P<.001).
ConclusionAmong U.S. Veterans with type 2 diabetes, initiators of semaglutide were not observed to have an increased risk of suicidality compared with initiators of SGLT2i. Those with longer semaglutide treatment (beyond 12 months) had decreased risk of suicide attempt or death, suggesting longer term treatment is safe and may protect against for those outcomes.
]]>2026-04-20doi:10.64898/2026.04.17.26351118Cold Spring Harbor Laboratory2026-04-20